Stefan H. Pohlmann

Wilhelm Weber Str. 2
Goettingen, NI 37073, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 206 publications

The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.

The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.

Journal: Journal of virology

Published: August 05, 2026

Pseudovirus-based analysis of host cell entry and vaccine-induced neutralisation of Bundibugyo virus.

Pseudovirus-based analysis of host cell entry and vaccine-induced neutralisation of Bundibugyo virus.

Journal: The Lancet. Infectious diseases

Published: July 01, 2026

Lock out: targeting TMPRSS2 to block influenza and coronaviruses.

Lock out: targeting TMPRSS2 to block influenza and coronaviruses.

Journal: Journal of virology

Published: May 04, 2026

Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4.

Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4.

Journal: Journal of virology

Published: April 06, 2026

Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution?

Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution?

Journal: The Lancet. Infectious diseases

Published: March 26, 2026

Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K.

Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K.

Journal: NPJ vaccines

Published: March 11, 2026

Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses.

Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses.

Journal: PloS one

Published: December 04, 2025

Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl Thioureas.

Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl Thioureas.

Journal: ChemMedChem

Published: November 07, 2025

Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation.

Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation.

Journal: The Lancet. Infectious diseases

Published: October 13, 2025

Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2.

Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2.

Journal: The Lancet. Infectious diseases

Published: September 23, 2025

Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.

Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.

Journal: Kidney medicine

Published: September 08, 2025

Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.

Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.

Journal: Virology

Published: August 22, 2025

Showing 1-12 of 206

Last Updated: 09/26/2026